SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-029114
Filing Date
2024-06-20
Accepted
2024-06-20 16:16:31
Documents
2
Period of Report
2024-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1718914583.html 4  
1 FORM 4 wk-form4_1718914583.xml 4 3265
2 EX-24 warrenpoa.htm EX-24 13259
  Complete submission text file 0001628280-24-029114.txt   18056
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3891 RANCHERO DRIVE SUITE 150 ANN ARBOR MI 48108
Business Address
Warren Eric (Reporting) CIK: 0001916048 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35986 | Film No.: 241056439